SEC Filing Document

Company: BIOVENTRIX, INC.
Ticker: 
CIK: 1283259
Filing Type: S-1/A
Document Type: S-1/A
Date Filed: 2026-03-18
Accession Number: 0001493152-26-010642
Exchange: 
SIC Code: 3841
SIC Description: Surgical & Medical Instruments & Apparatus
URL: https://www.sec.gov/Archives/edgar/data/1283259/000149315226010642/forms-1a.htm

Chunk 62 of 85
Word Count: 1498
Character Count: 9177

Document Content:

for any common stock, whether currently owned or subsequently acquired, without the prior written consent of the representative of the underwriters, for a period of six (6) months following the closing of this offering. addition, we have agreed, subject to certain exceptions, not to offer, sell, assign, transfer, pledge, contract to sell, or otherwise dispose of or announce the intention to otherwise dispose of, or enter into any swap, hedge or similar agreement or arrangement that transfers, in whole or in part, the economic risk of ownership of, directly or indirectly, engage in any short selling of any common stock or securities convertible into or exchangeable or exercisable for any common stock, whether currently owned or subsequently acquired, without the prior written consent of the representative of the underwriters, for a period of six (6) months following the closing of this offering. Delaware Law and Certain Charter and Bylaw Provisions

Our
Charter and Bylaws and the DGCL contain provisions, which are summarized in the following paragraphs, that are intended to enhance the
likelihood of continuity and stability in the composition of our board of directors. These provisions are intended to avoid costly takeover
battles, reduce our vulnerability to a hostile or abusive change of control and enhance the ability of our board of directors to maximize
stockholder value in connection with any unsolicited offer to acquire us. However, these provisions may have an anti-takeover effect
and may delay, deter or prevent a merger or acquisition of the Company by means of a tender offer, a proxy contest or other takeover
attempt that a stockholder might consider in its best interest, including those attempts that might result in a premium over the prevailing
market price for the shares of Common Stock held by stockholders.

Authorized
but Unissued Capital Stock

Delaware law does
not require stockholder approval for any issuance of shares that are authorized and available for issuance. However, the listing requirements
of the Nasdaq, which would apply so long as our Common Stock remains listed on the Nasdaq, require stockholder approval
of certain issuances equal to or exceeding 20% of the then outstanding voting power of our capital stock or then outstanding number of
shares of Common Stock. These additional shares may be used for a variety of corporate purposes, including future public offerings, to
raise additional capital or to facilitate acquisitions.

Our
board of directors may generally issue shares of one or more series of preferred stock on terms calculated to discourage, delay or prevent
a change of control of the Company or the removal of our management. Moreover, our authorized but unissued shares of preferred stock
will be available for future issuances in one or more series without stockholder approval and could be utilized for a variety of corporate
purposes, including future offerings to raise additional capital, to facilitate acquisitions and employee benefit plans.

One
of the effects of the existence of authorized and unissued and unreserved Common Stock or preferred stock may be to enable our board
of directors to issue shares to persons friendly to current management, which issuance could render more difficult or discourage an attempt
to obtain control of our company by means of a merger, tender offer, proxy contest or otherwise, and thereby protect the continuity of
our management and possibly deprive our stockholders of opportunities to sell their shares of Common Stock at prices higher than prevailing
market prices.

Delaware
Law

will not be subject to the provisions of Section 203 of the DGCL, regulating corporate takeovers. In general, those provisions prohibit
a Delaware corporation, including those whose securities are listed for trading on the Nasdaq, from engaging in any business combination
with any interested stockholder for a period of three years following the date that the stockholder became an interested stockholder,
unless:

●	the
transaction is approved by the board of directors before the date the interested stockholder
attained that status;

●	upon
consummation of the transaction that resulted in the stockholder becoming an interested stockholder,
the interested stockholder owned at least 85% of the voting stock of the corporation outstanding
at the time the transaction commenced; or

or after such time the business combination is approved by the board of directors and authorized
at a meeting of stockholders by at least two-thirds of the outstanding voting stock that
is not owned by the interested stockholder.

Removal
of Directors; Vacancies and Newly Created Directorships

Under
the DGCL, directors may be removed, with or without cause, by the holders of a majority of the shares then entitled to vote at an election
of directors. In addition, under the DGCL, subject to the rights granted to one or more series of preferred stock then outstanding, any
vacancies on our board of directors, and any newly created directorships, will be filled only by the affirmative vote of a majority of
the directors then in office, even if less than a quorum, by a sole remaining director or by the stockholders.

Cumulative Voting

Under
Delaware law, the right to vote cumulatively does not exist unless the certificate of incorporation specifically authorizes cumulative
voting. Our Charter does not authorize cumulative voting. Therefore, stockholders holding a majority in voting power of the shares of
our stock entitled to vote generally in the election of directors will be able to elect all our directors.

Special
Stockholder Meetings

Our
Bylaws provide that special meetings of our stockholders may be called at any time only by or at the direction of the board of directors.
Our Bylaws prohibit the conduct of any business at a special meeting other than as specified in the notice for such meeting. These provisions
may have the effect of deterring, delaying or discouraging hostile takeovers, or changes in control or management of the Company.

Director
Nominations and Stockholder Proposals

Our
Bylaws establish advance notice procedures with respect to stockholder proposals. In order for any matter to be “properly brought”
before a meeting, a stockholder will have to comply with advance notice requirements and provide us with certain information. For a stockholder’s
proposal to be timely, a stockholder’s notice , must be received by the Secretary at the principal executive offices of the Corporation
not later than the close of business on the 90th day nor earlier than the opening of business on the 120th day before the anniversary
date of the immediately preceding annual meeting of stockholders; provided, however, that in the event that the annual meeting is more
than 30 days before or more than 60 days after such anniversary date (or if there has been no prior annual meeting), notice by the stockholder
to be timely must be so delivered not earlier than the close of business on the 120th day before the meeting and not later than the later
of (x) the close of business on the 90th day before the meeting or (y) the close of business on the 10th day following the day on which
public announcement of the date of the annual meeting is first made by the Corporation. Our Bylaws also specify requirements as to the
form and content of a stockholder’s notice.

Our
Bylaws also establish advance notice procedures with respect to the nomination of candidates for election as directors, other than nominations
made by or at the direction of the board of directors or a committee of the board of directors. To be timely, a stockholder’s notice
to the Secretary must be received by the Secretary at the principal executive offices of the Corporation (i) in the case of an annual
meeting, not later than the close of business on the 90th day nor earlier than the close of business on the 120th day before the anniversary
date of the immediately preceding annual meeting of stockholders; provided, however, that in the event that the annual meeting is more
than 30 days before or more than 60 days after such anniversary date (or if there has been no prior annual meeting), notice by the stockholder
to be timely must be so received not earlier than the close of business on the 120th day before the meeting and not later than the later
of (x) the close of business on the 90th day before the meeting or (y) the close of business on the 10th day following the day on which
public announcement of the date of the annual meeting was first made by the Corporation; and (ii) in the case of a special meeting of
stockholders called for the purpose of electing directors, not later than the close of business on the 10th day following the day on
which public announcement of the date of the special meeting is first made by the Corporation. In no event shall the public announcement
of an adjournment or postponement of an annual meeting or special meeting commence a new time period (or extend any time period) for
the giving of a stockholder’s notice. Our Bylaws also specify requirements as to the form and content of a stockholder’s
notice.